Literature DB >> 464358

Efficacy of an inactivated virus vaccine for prevention of porcine parvovirus-induced reproductive failure.

W L Mengeling, T T Brown, P S Paul, D E Gutekunst.   

Abstract

Gilts vaccinated IM either once (4 gilts) or twice (2 gilts) with an acetylethyleneimine-inactivated porcine parvovirus (PPV) vaccine before they were bred were subsequently exposed intranasally and orally to virulent PPV at about the 40th day of gestation (from 37 to 43 days). At 2 weeks after vaccination, all had hemagglutination-inhibiting (HI) titers for PPV (from 20 to 80) which decreased by the time the immunity was challenged with virulent virus (from 10 to 40), but increased thereafter (from 160 to 1,280). Titers of singly and doubly vaccinated gilts were similar throughout the experiment. The gilts were killed at about the 84th day of gestation (from 80 to 87 days), and their litters were examined. Litters were comprised of 68 live fetuses and 1 dead fetus (7 to 14 fetuses/litter). Neither viral antigen, PPV, nor homologous HI antibody was found in any of the fetuses. In addition, 4 gilts were kept in contact with the vaccinated gilts and were treated similarly except for vaccination. These 4 gilts remained free of HI antibody until after they were exposed to virulent PPV during gestation. At the time the gilts were killed the titers were 1,280 to 2,560. Their litters were comprised of 11 live fetuses and 26 dead fetuses (8 to 11 fetuses/litter). Virus was isolated from fetuses of all litters. Viral antigen was found in 24 of the dead fetuses and 10 of the live fetuses. All infected live fetuses also had HI antibody for PPV. The 2 boars used to breed vaccinated and nonvaccinated gilts (usually each gilt was bred to each of the 2 boars), but not exposed to virulent PPV, remained free of HI antibody for PPV.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464358

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  16 in total

1.  Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.

Authors:  Qunxing Pan; Kongwang He; Yongshan Wang; Xiaoli Wang; Wei Ouyang
Journal:  Virus Genes       Date:  2013-02-21       Impact factor: 2.332

2.  Experience of vaccination against porcine parvovirus in pig-breeding herds: serological status and reproductive performance.

Authors:  S Einarsson; K Larsson; B Thafvelin
Journal:  Acta Vet Scand       Date:  1987       Impact factor: 1.695

3.  Outbreaks of porcine parvovirus disease in Panama.

Authors:  N Obaldia
Journal:  Trop Anim Health Prod       Date:  1991-08       Impact factor: 1.559

4.  Studies on porcine circovirus type 2 vaccination of 5-day-old piglets.

Authors:  K C O'Neill; H G Shen; K Lin; M Hemann; N M Beach; X J Meng; P G Halbur; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2011-09-21

5.  Detection of challenge virus in fetal tissues by nested PCR as a test of the potency of a porcine parvovirus vaccine.

Authors:  S Belák; E Rivera; A Ballagi-Pordány; W Hanzhong; F Widén; T Soós
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459

6.  Mapping and characterization of neutralizing epitopes of glycoproteins gIII and gp50 of the Indiana-Funkhauser strain of pseudorabies virus.

Authors:  N E Coe; W L Mengeling
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Vaccination against porcine parvovirus infection.

Authors:  K J Sørensen; J Askaa
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

8.  Inhibition of porcine parvovirus replication by empty virus particles.

Authors:  C S Choi; T W Molitor; H S Joo
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  Transplacental infection and embryonic death following maternal exposure to porcine parvovirus near the time of conception.

Authors:  W L Mengeling; P S Paul; T T Brown
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Porcine parvovirus: virus purification and structural and antigenic properties of virion polypeptides.

Authors:  T W Molitor; H S Joo; M S Collett
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.